Date returned
Item
Date returned
date
C0332156 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigational product container number - Returned
Item
Investigational product container number - Returned
text
C0304229 (UMLS CUI [1,1])
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0332156 (UMLS CUI [2])
Opened vials returned
Item
Opened vials returned
integer
C0184301 (UMLS CUI [1,1])
C0175566 (UMLS CUI [1,2])
C2699071 (UMLS CUI [2])
Unopened vials returned
Item
Unopened vials returned
integer
C0184301 (UMLS CUI [1,1])
C0587267 (UMLS CUI [1,2])
C2699071 (UMLS CUI [2])
Opened number 1 foils returned
Item
Opened number 1 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Unopened number 1 foils returned
Item
Unopened number 1 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0587267 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Opened number 2 foils returned
Item
Opened number 2 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Unopened number 2 foils returned
Item
Unopened number 2 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0587267 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Opened number 3 foils returned
Item
Opened number 3 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Unopened number 3 foils returned
Item
Unopened number 3 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0587267 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Opened number 4 foils returned
Item
Opened number 4 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Unopened number 4 foils returned
Item
Unopened number 4 foils returned
integer
C1551385 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0587267 (UMLS CUI [1,3])
C2699071 (UMLS CUI [2])
Date dispensed
Item
Date dispensed
date
C0947323 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigational product container number - Dispesed
Item
Investigational product container number - Dispesed
text
C0304229 (UMLS CUI [1,1])
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0947323 (UMLS CUI [2])
Did the subject receive a ranibizumab re-injection?
Item
Did the subject receive a ranibizumab re-injection?
boolean
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
Date/Time of ranibizumab injection in the study eye
Item
Date/Time of ranibizumab injection in the study eye
datetime
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2])
C0040223 (UMLS CUI [3])
Item
Reason for re-injection
text
C1272883 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Reason for re-injection
CL Item
Evidence of intraretinal fluid or subretinal fluid (subfoveal and extrafoveal accumulations) (9)
CL Item
A serous retinal pigment epithelial detachment (PED) that would benefit from re-injection (10)
CL Item
Notable decline in VA (a decrease of > 5 letters from any earlier maximum VA during the study if, in the opinion of the investigator, the VA decline is due to neovascular AMD) (3)
CL Item
New subretinal or intraretinal macular hemorrhage (11)
CL Item
Increased lesion size on FA relative to the last angiogram (5)
CL Item
Leakage on FA that would benefit from re-injection (12)
CL Item
Other, specify (OT)
If other reason for re-injection, specify
Item
If other reason for re-injection, specify
text
C1272883 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Date and Time of ranibizumab injection in the study eye
Item
Date and Time of ranibizumab injection in the study eye
datetime
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])
Item
Have you observed any of the following findings?
integer
C0243095 (UMLS CUI [1])
Code List
Have you observed any of the following findings?
CL Item
Evidence of intraretinal fluid or subretinal fluid (subfoveal and extrafoveal accumulations) (9)
CL Item
A serous retinal pigment epithelial detachment (PED) that would benefit from ongoing injections (13)
CL Item
Notable decline in VA (a decrease of > 5 letters from any earlier maximum VA during the study if, in the opinion of the investigator, the VA decline is due to neovascular AMD) (3)
CL Item
New subretinal or intraretinal macular hemorrhage (11)
CL Item
Increased lesion size relative to last angiogram (if FA was performed) (5)
CL Item
Leakage that would benefit from ongoing injections (if FA was performed) (14)